SCHEMBL26435529

SCHEMBL26435529

c1cc(-c2nc(-c3ccc(-c4cccc5sc6ccccc6c45)cc3)nc(-c3cccc4oc5ccccc5c34)n2)cc(-c2cccc3ccc4ccccc4c23)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
BACE1 P56817 1/20 0.32
MAPK1 P28482 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
BRDT Q58F21 1/20 0.32
ABCG2 Q9UNQ0 4/20 0.31
LIMK1 P53667 1/20 0.31
S1PR5 Q9H228 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435700 0.96 TDP1 (0.35) TDP1L3MBTL1BACE1MAPK1KDM4E
SCHEMBL26435444 0.96 TDP1 (0.35) TDP1L3MBTL1BACE1MAPK1KDM4E
SCHEMBL27368743 0.93 F9 (0.33) TDP1L3MBTL1BACE1MAPK1KDM4E
SCHEMBL26435126 0.91 ALOX5 (0.38) TDP1L3MBTL1MAPTBRDTABCG2
SCHEMBL26435486 0.91 ALOX5 (0.38) TDP1L3MBTL1MAPTBRDTABCG2
SCHEMBL24990880 0.91 TDP1 (0.36) TDP1L3MBTL1BACE1MAPK1KDM4E
SCHEMBL26435483 0.91 TDP1 (0.33) TDP1L3MBTL1BACE1MAPK1KDM4E
SCHEMBL25504969 0.91 BRDT (0.33) MAPK1KDM4EALDH1A1MAPTHPGD
SCHEMBL24656807 0.91 S1PR5 (0.38) BACE1KDM4EALDH1A1TP53MAPT
SCHEMBL25645973 0.91 BRDT (0.34) TDP1L3MBTL1BACE1MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 TDP1 1017/4885L3MBTL1 1536/4885BACE1 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.